<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">

Medicare Advantage vs Traditional Medicare: Cancer Drug Cost Disparities Explored

by The ASCO Post | January 13, 2025
placeholder

A CU Cancer Center study led by CU Cancer Center Deputy Director, Cathy Bradley, PhD, reveals that Medicare Advantage patients with colorectal cancer are less likely to receive high-cost drugs compared to those on traditional Medicare. 

Topics: Press Coverage